Basic Information | Post buying leads | Suppliers |
Name |
Oxeladine citrate |
EINECS | N/A |
CAS No. | 16485-39-5 | Density | N/A |
PSA | N/A | LogP | N/A |
Solubility | N/A | Melting Point |
N/A |
Formula | C20H33NO3•xC6H8O7 | Boiling Point | N/A |
Molecular Weight | N/A | Flash Point | N/A |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion, subcutaneous, and intravenous routes. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | 3 | |
Synonyms |
N/A |
IUPAC Name: 3-Carboxy-3,5-dihydroxy-5-oxopentanoate; diethyl-[2-[2-(2-ethyl-2-phenylbutanoyl)oxyethoxy]ethyl]azanium
Synonyms of Oxeladine citrate (CAS NO.16485-39-5) : 2-[2-(Diethylamino)ethoxy]ethyl 2-ethyl-2-phenylbutanoate 2-hydroxypropane-1,2,3-tricarboxylate (1:1) ; Benzeneacetic acid, alpha,alpha-diethyl-, 2-[2-(diethylamino)ethoxy]ethyl ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt) ; Batoril ; Bronchell
CAS NO: 16485-39-5
Molecular Formula:C26H41NO10
Molecular Weight :527.6044
Molecular Structure :
Flash Point: 208.5 °C
Enthalpy of Vaporization: 67.51 kJ/mol
Boiling Point: 421.2 °C at 760 mmHg
Vapour Pressure: 2.66E-07 mmHg at 25°C
Oxeladine citrate (CAS NO.16485-39-5) is used as intermediate in organic synthesis.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intravenous | 13mg/kg (13mg/kg) | Drugs in Japan Vol. 6, Pg. 157, 1982. | |
mouse | LD50 | oral | 130mg/kg (130mg/kg) | Drugs in Japan Vol. 6, Pg. 157, 1982. | |
mouse | LD50 | subcutaneous | 244mg/kg (244mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD | Yakugaku Zasshi. Journal of Pharmacy. Vol. 82, Pg. 1314, 1962. |
rat | LD50 | oral | 183mg/kg (183mg/kg) | Drugs in Japan Vol. 6, Pg. 157, 1982. |
Poison by ingestion, subcutaneous, and intravenous routes. When Oxeladine citrate (CAS NO.16485-39-5) is heated to decomposition, it emits toxic fumes of NOx.